Skip to content

A clinical study comparison between two groups of intestinal tract cleansing agents for colon capsule endoscopy based on the colonoscopy as a golden standard, and usefulness of interpretation support by clinical engineering technologist.

A clinical study comparison between two groups of intestinal tract cleansing agents for colon capsule endoscopy based on the colonoscopy as a golden standard, and usefulness of interpretation support by clinical engineering technologist. - A clinical study comparison between two groups of intestinal tract cleansing agents for colon capsule endoscopy based on the colonoscopy as a golden standard, and usefulness of interpretation support by clinical engineering technologist.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000029398
Enrollment
20
Registered
2017-10-03
Start date
2017-06-05
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

suspect of colorectal cancer

Interventions

1) The method of intestinal tract cleansing
2 days before the test, take 2 aperient tablets. The day before, take 190 ml of intestinal cleansing agent. The day of testing, take 1L of intestinal cleansing agent and 500 ml of water before swallow
2 days before the test, take 2 aperient tablets. The day before, take 1510 ml of intestinal cleansing agent. The day of testing, after swallowing the capsule, until the release of the capsule is confi

Sponsors

Public Interest Incorporated Association, Kagoshima, Nanpuh Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Person among our staff who judged that need for colon examination with symptoms such as hematochezia and long term constipation and/ or diarrhea by the doctor. 2. Person who agreed to participate in this research with written informed consent, and obtained voluntary written agreement with sufficient understanding after receiving sufficient explanation in participating in this research. 3. Person who aged 20 years or older and under 70 years old when obtaining the consent.

Exclusion criteria

Exclusion criteria: 1. Person who has dysphagia disorder. 2. Person who have a history of allergic to drugs used in this study. 3. A woman who is pregnant or suspected to be pregnant. 4. Person who will undergo MRI within 2 weeks after colon capsule endoscopy. 5. Person who have a history of abdominal surgery, and there is a possibility of adhesion. 6. Person with present or past history of small and large bowel obstruction. 7. Person who suspicious of having colorectal advanced carcinoma by tumor markers or symptoms. 8. Person inappropriate for this study by other reasons judged by investigators.

Design outcomes

Primary

MeasureTime frame
1. Comparison between two groups of intestinal tract washing method. Acceptability of whole examination including questionnaire degree of intestinal tract, intestinal tract washing method (questionnaire) 2. Utility of colon capsule endoscope with colonoscopy as a golden standard Colon capsule endoscope total colon observation rate, colon lesion detection rate 3. Usefulness of interpretation support by clinical engineering technologist. Lesion detection rate, interpretation time by doctor 4. Other Clinical information (gender, age, height, body weight, reason for colon examination, etc.)

Countries

Japan

Contacts

Public ContactSyuko Minami

Public Interest Incorporated Association, Kagoshima, Nanpuh Hospital Clinical Research Support Office

crc-kenkyu@nanpuh.or.jp099-805-2663

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026